Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 810
2021 1054
2022 924
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

2,542 results
Results by year
Filters applied: . Clear all
Page 1
Severity of COVID-19 in patients with lung cancer: evidence and challenges.
Passaro A, Bestvina C, Velez Velez M, Garassino MC, Garon E, Peters S. Passaro A, et al. J Immunother Cancer. 2021 Mar;9(3):e002266. doi: 10.1136/jitc-2020-002266. J Immunother Cancer. 2021. PMID: 33737345 Free PMC article. Review.
Different small and large-scale registries, such as the COVID-19 and Cancer Consortium (CCC19) and Thoracic Cancers International COVID-19 Collaboration quickly collected data, supporting cancer care decisions under the challenging circum …
Different small and large-scale registries, such as the COVID-19 and Cancer Consortium (CCC19) and Thoracic Cancers Int …
How to interpret and use COVID-19 serology and immunology tests.
Ong DSY, Fragkou PC, Schweitzer VA, Chemaly RF, Moschopoulos CD, Skevaki C; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Ong DSY, et al. Clin Microbiol Infect. 2021 Jul;27(7):981-986. doi: 10.1016/j.cmi.2021.05.001. Epub 2021 May 8. Clin Microbiol Infect. 2021. PMID: 33975005 Free PMC article. Review.
For certain indications, including delayed disease presentations, serological tests can have added value. The presence of antibodies against SARS-CoV-2 may indicate a recent or past COVID-19 infection. ...T-cell responses against SARS
For certain indications, including delayed disease presentations, serological tests can have added value. The presence of antibodies …
Cancer and COVID-19: analysis of patient outcomes.
Aboueshia M, Hussein MH, Attia AS, Swinford A, Miller P, Omar M, Toraih EA, Saba N, Safah H, Duchesne J, Kandil E. Aboueshia M, et al. Future Oncol. 2021 Sep;17(26):3499-3510. doi: 10.2217/fon-2021-0121. Epub 2021 Jul 15. Future Oncol. 2021. PMID: 34263660 Free PMC article.
Background: We sought to investigate the outcomes associated with COVID-19 disease in cancer patients. Methods: We conducted a retrospective cohort study of laboratory-confirmed COVID-19 patients. ...In this study, we aimed to investigate how …
Background: We sought to investigate the outcomes associated with COVID-19 disease in cancer patients. Methods: We cond …
COVID-19 and lung pathologies.
Purohit D, Ahirwar AK, Sakarde A, Asia P, Gopal N. Purohit D, et al. Horm Mol Biol Clin Investig. 2021 Aug 2;42(4):435-443. doi: 10.1515/hmbci-2020-0096. Horm Mol Biol Clin Investig. 2021. PMID: 34333882 Review.
The SARS CoV-2 is a RNA virus belonging to the family coronaviridae. ...The occurrence of COVID-19 in COPD patients can be related with smoking. The ACE-2 expression in such patients was considerably high. ...
The SARS CoV-2 is a RNA virus belonging to the family coronaviridae. ...The occurrence of COVID-19 in COP …
COVID-19 in patients with lung cancer.
Luo J, Rizvi H, Preeshagul IR, Egger JV, Hoyos D, Bandlamudi C, McCarthy CG, Falcon CJ, Schoenfeld AJ, Arbour KC, Chaft JE, Daly RM, Drilon A, Eng J, Iqbal A, Lai WV, Li BT, Lito P, Namakydoust A, Ng K, Offin M, Paik PK, Riely GJ, Rudin CM, Yu HA, Zauderer MG, Donoghue MTA, Łuksza M, Greenbaum BD, Kris MG, Hellmann MD. Luo J, et al. Ann Oncol. 2020 Oct;31(10):1386-1396. doi: 10.1016/j.annonc.2020.06.007. Epub 2020 Jun 17. Ann Oncol. 2020. PMID: 32561401 Free PMC article.
BACKGROUND: Patients with lung cancers may have disproportionately severe coronavirus disease 2019 (COVID-19) outcomes. ...Although severe, COVID-19 accounted for a minority of overall lung cancer deaths …
BACKGROUND: Patients with lung cancers may have disproportionately severe coronavirus disease 2019 (COVID
COVID-19 and lung cancer: risks, mechanisms and treatment interactions.
Addeo A, Obeid M, Friedlaender A. Addeo A, et al. J Immunother Cancer. 2020 May;8(1):e000892. doi: 10.1136/jitc-2020-000892. J Immunother Cancer. 2020. PMID: 32434788 Free PMC article.
Cases of the 2019 novel coronavirus also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to rise worldwide. ...Therefore, these patients might be at increased risk of pulmo …
Cases of the 2019 novel coronavirus also known as severe acute respiratory syndrome coronavirus
COVID and Lung Cancer.
Calabrò L, Rossi G, Covre A, Morra A, Maio M. Calabrò L, et al. Curr Oncol Rep. 2021 Oct 22;23(11):134. doi: 10.1007/s11912-021-01125-8. Curr Oncol Rep. 2021. PMID: 34677721 Free PMC article. Review.
PURPOSE OF REVIEW: Since the past year, the fast spread of coronavirus disease 2019 (COVID-19) has represented a global health threat, especially for cancer patients, that has required an urgent reorganization of clinical activities. ...RECENT F …
PURPOSE OF REVIEW: Since the past year, the fast spread of coronavirus disease 2019 (COVID-19) has represented a …
Lung Cancer, Covid-19 Infections and Chemotherapy.
Haineala B, Zgura A, Badiu DC, Iliescu L, Anghel RM, Bacinschi XE. Haineala B, et al. In Vivo. 2021 May-Jun;35(3):1877-1880. doi: 10.21873/invivo.12450. In Vivo. 2021. PMID: 33910875 Free PMC article.
The impacts are multiple especially for patients cared for cancer. The Covid-19 epidemic has several impacts on the management of lung cancer patients. ...CONCLUSION: Data presented in this registry suggest a high mortality in patients with thor …
The impacts are multiple especially for patients cared for cancer. The Covid-19 epidemic has several impacts on the man …
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report.
Mazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, Farjah F, Fong KM, Iaccarino JM, Janes SM, Kanne JP, Kazerooni EA, MacMahon H, Naidich DP, Powell CA, Raoof S, Rivera MP, Tanner NT, Tanoue LK, Tremblay A, Vachani A, White CS, Wiener RS, Silvestri GA. Mazzone PJ, et al. Chest. 2020 Jul;158(1):406-415. doi: 10.1016/j.chest.2020.04.020. Epub 2020 Apr 23. Chest. 2020. PMID: 32335067 Free PMC article.
BACKGROUND: The risks from potential exposure to coronavirus disease 2019 (COVID-19), and resource reallocation that has occurred to combat the pandemic, have altered the balance of benefits and harms that informed current (pre-COVID-19) …
BACKGROUND: The risks from potential exposure to coronavirus disease 2019 (COVID-19), and resource reallocation …
COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary.
Round T, L'Esperance V, Bayly J, Brain K, Dallas L, Edwards JG, Haswell T, Hiley C, Lovell N, McAdam J, McCutchan G, Nair A, Newsom-Davis T, Sage EK, Navani N. Round T, et al. Br J Cancer. 2021 Aug;125(5):629-640. doi: 10.1038/s41416-021-01361-6. Epub 2021 May 10. Br J Cancer. 2021. PMID: 33972746 Free PMC article. Review.
Delivering lung cancer care during the COVID-19 pandemic has posed significant and ongoing challenges. There is a lack of published COVID-19 and lung cancer evidence-based reviews, including for the whole patient pathway. .. …
Delivering lung cancer care during the COVID-19 pandemic has posed significant and ongoing challenges. There is …
2,542 results